Results 211 to 220 of about 227,260 (247)

Splenic Infarction and Recurrent Pulmonary Embolism in Atrial Fibrillation Associated With Subtherapeutic Anticoagulation and Medication Nonadherence: A Case Report. [PDF]

Cureus
Fares T, Hachem R, Mayow A, Shahzad MA.
europepmc   +1 more source

Adjuvant therapy of severe and/or refractory bullous pemphigoid with immunoadsorption – A prospective monocenter pilot study

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background and Objectives Bullous pemphigoid (BP) is the most common autoimmune blistering disease in the Western world. While remission is achieved in the majority of BP patients by long‐term use of corticosteroids with or without immunomodulants/immunosuppressants, national and international guidelines recommend adjuvant immunoadsorption (IA)
Maike M. Holtsche, Nina van Beek, Christoph M. Hammers, Artem Vorobyev, Michael Kasperkiewicz, Nina Schumacher, Philip Muck, Enno Schmidt   +7 more
wiley   +1 more source

Cardioembolic sources and stroke prevention: a systematic review. [PDF]

Cardiovasc Ultrasound
Cozza E, Cito V, Giumbini G, Marsili G, Barletta M, Zannoni J, Mainardi C, Bedogni F, Tusa M.   +8 more
europepmc   +1 more source

Minimal intraoperative anticoagulation strategy for lung transplantation with preoperative heparin-induced thrombocytopenia. [PDF]

JHLT Open
Bagrodia N, Alvarez AV, Gouchoe DA, Whitson BA, Henn MC, Choi K.   +5 more
europepmc   +1 more source

Acalabrutinib in Chronic Lymphocytic Leukemia: Pharmacology and Emerging Clinical Perspectives

European Journal of Haematology, EarlyView.
ABSTRACT Acalabrutinib, a second‐generation Bruton's tyrosine kinase inhibitor (BTKi), is characterized by enhanced specificity and selectivity for BTK with minimal off‐target effects, offering a significant evolution in the treatment of chronic lymphocytic leukemia (CLL). Its mechanism of action, a covalent binding to Cys481 within the BTK active site,
Gianluca Gaidano, Romano Danesi
wiley   +1 more source

Transjugular intrahepatic portosystemic shunt improves survival in anticoagulation-resistant hepatic sinusoidal obstructive syndrome patients: A multicenter retrospective study. [PDF]

World J Hepatol
Tu JJ, Zhang H, Kong DR, Feng YH, Yu YC, Li TS, Zhang F, Zhang W, Xu H, Yin Q, Wang L, Zhang M, Xiao JQ, Zhuge YZ.   +13 more
europepmc   +1 more source

Postoperative Care and Management in Pediatric Hematology‐Oncology Patients

European Journal of Haematology, EarlyView.
ABSTRACT Pediatric patients with hematologic and oncologic diseases often undergo surgical procedures as part of diagnosis and therapy. These include central venous catheter placements, tumor resections, lymph node and bone marrow biopsies, among others.
Shachi Srivatsa, Sara A. Mansfield
wiley   +1 more source

Extended treatment for venous thromboembolism: Is direct oral anticoagulant dose-reduction better for all? [PDF]

Hemasphere
Lauw MN, Middeldorp S, Carrier M.
europepmc   +1 more source

Fostamatinib treatment for patients with antiphospholipid syndrome and low platelet count: A case series

British Journal of Haematology, EarlyView.
Ekaterina Balaian, Rosa Sonja Alesci, Sandra Marten, Julia‐Annabell Georgi, Christiane Naue, Martin Bornhäuser, Karolin Trautmann‐Grill   +6 more
wiley   +1 more source